News

Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being ...
Assessment of sexual dysfunction among adult male survivors of childhood cancer has primarily been limited to erectile dysfunction. This study aimed to characterize sexual functioning more ...
The 780 articles in this study collectively cited 42,976 references. After analyzing the top 10 most frequently cited references, we found that the majority of these references are research articles, ...
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online ...
In this study, a patient with tirzepatide was delayed due to delayed gastric emptying, resulting in gastrointestinal tract clearance during the procedure. In a retrospective study of patients who ...
Testosterone deficiency (TD) affects 18-38% of men undergoing radical prostatectomy (RP) for localised prostate cancer and may impair postoperative sexual rehabilitation. Testosterone replacement ...
Eli Lilly and Company is conducting a clinical study titled ‘Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in ...
Lilly’s tirzepatide shortage ended first, with the FDA officially declaring the situation resolved early last October. The regulator erased Novo’s semaglutide from its shortage list in February.